Resolution of advanced conjunctival squamous cell carcinoma with cemiplimab immunotherapy, IFNα-2b, and retinoic acid treatment over 2 years of follow-up

Can J Ophthalmol. 2024 Apr 6:S0008-4182(24)00070-X. doi: 10.1016/j.jcjo.2024.03.011. Online ahead of print.

¹ College of Medicine, University of Saskatchewan, Saskatoon, SK. Electronic address: Brooklyn.rawlyk@usask.ca.
² Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB.
³ College of Medicine, University of Saskatchewan, Saskatoon, SK; Allan Blair Cancer Centre, Sask Cancer Agency, Regina, SK.
⁴ College of Medicine, University of Saskatchewan, Saskatoon, SK; Department of Ophthalmology, University of Saskatchewan, Saskatoon, SK.

No abstract available

Publication types